We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Three researchers in a lab.
Product News

Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

Codexis, Inc. (NASDAQ: CDXS), announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing.
An RNA strand.
Product News

TriLink BioTechnologies Collaborates With Johns Hopkins University To Establish a New RNA Innovation Center

The collaborative center will help to lower barriers to RNA innovation and discovery.
A female doctor and a patient looking at an ipad screen.
Product News

Phesi Launches Predictive Patient Burden Score To Improve Trial Efficiency, Patient Experience and Investigator Site Performance

Latest real-world metric in Phesi’s AI-driven Trial Accelerator™ quantifies patient burden to unlock a patient-centric approach to trial design and implementation.
A test tube held in front of a DNA model.
Product News

Circio Presents Pre-Clinical Proof-of-Concept Data for Its circVec Gene Therapy Platform at the ASGCT 2024 Meeting

Two posters demonstrate in vivo superiority of circular RNA vs. linear mRNA-based expression and technical proof-of-concept for Circio´s ´remove-&-replace´ gene therapy format for the unmet medical need AATD.
An individual holding up an eco friendly rack.
Product News

The Eco-Friendly Choice for Sample Storage

Micronic, proudly unveils its latest innovation: an Eco-Friendly Rack Range. These Eco-Friendly Choice (EFC) Racks are made of 99% in-house renewed material (RM), setting a new sustainable standard for sample storage racks.
A labelled antibody and a cell.
Product News

FDA-Approved TIVDAK®: Targeting Tissue Factor in Cervical Cancer

On April 29th, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after chemotherapy.
A box of orviglance.
Product News

Ascelia Pharma Successfully Meets Primary Endpoint With Strong Headline Results in Orviglance Phase 3 Study

Ascelia Pharma AB (publ) (ticker: ACE), announced that liver imaging drug candidate, Orviglance®, significantly improved visualization of focal liver lesions, successfully meeting the primary endpoint in the pivotal Phase 3 study SPARKLE.
Cells.
Product News

Touchlight, Cell and Gene Therapy Catapult and Complement Therapeutics To Develop Innovative Manufacturing Process for Gene Therapies

The Cell and Gene Therapy Catapult (CGT Catapult), Touchlight, announce that they have been awarded over £1 million in a grant from Innovate UK, as part of the ‘Innovative Technologies: Nucleic Acid Medicines Manufacture’ competition.
Antibodies.
Product News

Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents To Support Preclinical Immunogenicity Assessment

Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples.
Cell therapy.
Product News

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

ProPharma, announced that in partnership with PBL, it developed an enclosed, fully automated cell factory device, the Cell Factory Box (CF Box).
Advertisement